ARTICLE
24 March 2023

AG Garland Signals That Department Of Justice's Cannabis Policy Will Be "Very Close" To Cole Memorandum

M
Mintz

Contributor

Mintz is a general practice, full-service Am Law 100 law firm with more than 600 attorneys. We are headquartered in Boston and have additional US offices in Los Angeles, Miami, New York City, San Diego, San Francisco, and Washington, DC, as well as an office in Toronto, Canada.
In his March 1, 2023 testimony before the United States Senate, Attorney General Merrick Garland indicated that the Department of Justice's (DOJ) marijuana policy will harken back to 2013.
United States Food, Drugs, Healthcare, Life Sciences

In his March 1, 2023 testimony before the United States Senate, Attorney General Merrick Garland indicated that the Department of Justice's (DOJ) marijuana policy will harken back to 2013, when then-Attorney General James Cole issued what became known as the "Cole Memo." The Cole Memo carved out eight enforcement priorities that DOJ identified as "particularly important," including prevention of distribution of marijuana to minors, revenue from flowing to criminal enterprises, the use of marijuana activity as a front for other illegal acts, and violence or threats to public safety. Otherwise, Attorney General Cole wrote, the federal government intended to rely on state and local law enforcement to address cannabis under their own regulatory schemes.

This hands-off approach guided the federal government's marijuana enforcement efforts until Attorney General Jeff Sessions rescinded the Cole Memo in 2018. Not much changed following rescission, but the cannabis industry welcomed President Biden's announcement in October 2022 indicating prior federal offenses for simple possession of marijuana should be pardoned and requesting that the Department of Health and Human Services and the Attorney General initiate an administrative process to revisit marijuana's classification under the Controlled Substances Act as a Schedule I drug.

AG Garland's testimony brings us full circle back to 2013, and may indicate that the AG does not intend to recommend de-scheduling marijuana.

In the meantime, Mintz will continue to monitor these issues as they develop.

AG Garland's testimony brings us full circle back to 2013, and may indicate that the AG does not intend to recommend de-scheduling marijuana.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More